Angiogenesis inhibiting molecules and their use in the...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/30 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) C07K 16/46 (2006.01) C07K 19/00 (2006.01) C12N 5/20 (2006.01) C12N 15/13 (2006.01) G01N 33/566 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2546406

The present invention relates to angiogenesis inhibiting molecules that are the monoclonal antibody H33 or fragments or derivatives thereof, to their use in the treatment of cancer, in particular the treatment of solid tumors and to therapeutical and diagnostic compositions comprising them. The invention relates in particular to humanized derivatives of H33 or human monoclonal antibodies having the specificity of H33.

La présente invention concerne des molécules inhibitrices d'angiogenèse qui sont des anticorps H33 monoclonaux, des fragments ou des dérivés de ceux-ci, leur utilisation dans le traitement du cancer, en particulier le traitement de tumeurs solides, des compositions thérapeutiques et diagnostiques comprenant ces molécules. Cette invention concerne aussi des dérivés humanisés de H33 ou des anticorps monoclonaux humains possédant la spécificité de H33.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Angiogenesis inhibiting molecules and their use in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiogenesis inhibiting molecules and their use in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibiting molecules and their use in the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1872867

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.